Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAltitude Group Regulatory News (ALT)

Share Price Information for Altitude Group (ALT)

Share Price is delayed by 15 minutes
Get Live Data
20.50    0.50 (2.50%)
Bid:
20.00
Ask:
21.00
Spread: 1.00 (5.00%)
Market Cap: £14.99m
ALT Live PriceLast checked at - London Stock Exchange

Intraday Altitude Group Share Chart

Year-end trading update

10 Apr 2019 07:00

RNS Number : 6859V
Altitude Group PLC
10 April 2019
 

10 April 2019

ALTITUDE GROUP PLC

("Altitude", the "Group" or the "Company")

 

Year-end trading update, results notification and post-acquisition update

 

Altitude Group plc (AIM: ALT), the operator of a leading marketplace for personalised products, is pleased to provide a trading update for the year ended 31 December 2018 and to provide an update for the period following the successful equity placing and acquisition of Advertising Industry Mastermind Group, LLC ("AI Mastermind").

 

Trading for the year ended 31 December 2018 was in line with market expectations and the Group expects to announce its Preliminary Results for this period on 28 May 2019.

 

The Board is encouraged with the progress made since the acquisition of AI Mastermind, the largest promotional products distributor organization member group in the US. Integration has gone well, with the team focussed on driving revenue from, and delivering value to, both sides of the supply chain, increasing member order volumes and value to our supply partners. The business is continuing to increase membership and generate revenue through enhanced marketing, technology and sales support with a particular focus on the supply chain. As announced on 11 March 2019 we have made, and continue to make, key additions to the team in the US who will help to support and accelerate the opportunities available to us.

Nichole Stella, Chief Executive Officer, commented:

 

"The Company made substantial progress in 2018 and has developed further in the short period following the acquisition of AI Mastermind and its subsequent rapid, successful integration. We have made good initial progress and are encouraged that both members and supplier partners are recognising our enhanced, combined service. We are more convinced than ever about the potential of our model and of the benefits that will be derived following the acquisition of AI Mastermind. The Board looks forward to providing a more detailed update on progress and the exciting evolution of the business on 28 May 2019 when we publish our year end results."

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014 of the Market Abuse Regulation

 

Enquiries:

 

Altitude Group plc - via Instinctif Partners 020 7457 2020

Nichole Stella, Chief Executive Officer

Graeme Couturier, Chief Financial Officer

Peter Hallett, Non-Executive Chairman

 

finnCap Ltd 020 7220 0500

Jonny Franklin-Adams / Scott Mathieson (Corporate Finance)

Richard Chambers (ECM)

 

Instinctif Partners 020 7457 2020

Matthew Smallwood

Chantal Woolcock

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUKOWRKVASRAR
Date   Source Headline
8th Jun 20267:00 amRNSDirector/PDMR Shareholding
1st Jun 20268:31 amRNSExercise & Grant of Options and TVR
17th Apr 20267:00 amRNSBoard Role Change
14th Apr 20263:25 pmRNSDirector/PDMR Dealing
9th Apr 202612:00 pmRNSDirector/PDMR Dealing
31st Mar 20267:00 amRNSTrading Update
5th Mar 20263:39 pmRNSDirector/PDMR Shareholding
5th Mar 20267:00 amRNSAppointment of Independent Non-Executive Director
10th Feb 202612:32 pmRNS-RAppointment of Chief Commercial Officer
4th Feb 20267:00 amRNSAppointment of Nominated Adviser and Sole Broker
19th Jan 20261:33 pmRNSPDMR Dealing
23rd Dec 20257:00 amRNSPDMR Dealing
23rd Dec 20257:00 amRNSPDMR Dealing
1st Dec 20259:01 amRNSPDMR Dealing
28th Nov 20257:00 amRNSChange of Registered Office
27th Nov 20254:57 pmRNSCorrection: Exercise & Grant of Options and TVR
27th Nov 20257:30 amRNSExercise & Grant of Options, PDMR Dealings and TVR
27th Nov 20257:00 amRNSInterim Results
11th Nov 20257:00 amRNSTrading Update, Board Change and Notice of Results
30th Oct 20257:00 amRNSHolding(s) in Company
26th Sep 20257:00 amRNSResult of AGM
12th Sep 20257:00 amRNSDirector/PDMR Dealing
11th Sep 20257:00 amRNSDirector/PDMR Dealing
10th Sep 20257:00 amRNSDirector/PDMR Dealing
8th Sep 20257:00 amRNSDirector/PDMR Dealing
5th Sep 20257:00 amRNSDirector/PDMR Dealing
15th Aug 20254:20 pmRNSChange of Venue for the 2025 AGM
7th Aug 20257:00 amRNSAudited Annual Results and Notice of AGM
30th Jul 20257:00 amRNSNotice of Results
15th Jul 20257:00 amRNSBoard Changes and Trading Update
23rd Jun 20257:00 amRNSAppointment of CFO
17th Jun 20257:00 amRNSBoard Change and Trading Update
15th May 20257:00 amRNSGrant of Options and PDMR Dealings
9th May 20255:50 pmRNSDirector/PDMR Dealing
9th Apr 20257:00 amRNSExercise of Options, Director Dealings and TVR
1st Apr 20257:00 amRNSDirector/PDMR Dealing
31st Mar 20257:00 amRNSTrading Update and New University Contract Awards
28th Mar 20257:00 amRNSChange of Registered Office
11th Mar 20257:00 amRNSDirector/PDMR Dealings
6th Mar 20257:00 amRNSDirectorate Change
3rd Dec 20247:00 amRNSInterim Results
15th Nov 20247:00 amRNSTrading Update and Notice of Results
8th Oct 20244:04 pmRNSHolding(s) in Company
23rd Sep 20244:47 pmRNSResult of AGM
6th Sep 202412:30 pmRNSPosting of Annual Report and Notice of AGM
30th Jul 20247:00 amRNSAudited Annual Results and Notice of AGM
23rd Jul 20247:00 amRNSFull Year Trading Update
3rd Jun 20249:28 amRNSExercise of Options, Director Dealings and TVR
20th May 20247:00 amRNSGrant of Options and PDMR Dealings
1st May 20247:00 amRNSPre-Close Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.